Cold & Cough Remedies (Pharmacies) - Western Africa

  • Western Africa
  • Revenue in the Cold & Cough Remedies market is projected to reach US$0.38bn in 2024.
  • Revenue is expected to show an annual growth rate (CAGR 2024-2029) of 11.33%, resulting in a market volume of US$0.65bn by 2029.
  • In global comparison, most revenue will be generated in China (US$7,826.00m in 2024).
  • In relation to total population figures, per person revenues of US$0.93 are generated in 2024.

Key regions: Canada, United Kingdom, United States, China, Europe

 
Market
 
Region
 
Region comparison
 
Currency
 

Analyst Opinion

The Cold & Cough Remedies (Pharmacies) market in Western Africa is experiencing significant growth and development.

Customer preferences:
Customers in Western Africa have shown a strong preference for over-the-counter cold and cough remedies available in pharmacies. This preference can be attributed to the convenience of purchasing these remedies without a prescription, as well as the affordability compared to visiting a doctor. Additionally, customers in this region value products that provide quick relief from symptoms such as coughing, congestion, and sore throat.

Trends in the market:
One of the key trends in the Cold & Cough Remedies (Pharmacies) market in Western Africa is the increasing demand for natural and herbal remedies. Customers are becoming more conscious of the potential side effects of synthetic medications and are seeking alternative options. This trend is driven by a growing interest in traditional medicine and a desire for more holistic approaches to healthcare. As a result, pharmacies are expanding their product offerings to include a wider range of natural remedies, such as herbal teas, essential oils, and traditional herbal formulations. Another trend in the market is the rise of private label brands. Pharmacies in Western Africa are increasingly developing their own private label cold and cough remedies to cater to the specific needs and preferences of their customers. These private label brands often offer competitive pricing and are trusted by customers due to their association with the pharmacy. This trend is driven by the desire to differentiate from competitors and increase customer loyalty.

Local special circumstances:
One of the unique circumstances in Western Africa is the prevalence of seasonal cold and cough outbreaks. The region experiences distinct dry and rainy seasons, which can lead to an increase in respiratory infections. This seasonal pattern drives the demand for cold and cough remedies during specific times of the year. Pharmacies in Western Africa need to anticipate and stock up on these remedies to meet the increased demand during peak seasons.

Underlying macroeconomic factors:
The development of the Cold & Cough Remedies (Pharmacies) market in Western Africa is also influenced by underlying macroeconomic factors. The region has been experiencing steady economic growth, resulting in an expanding middle class with increased purchasing power. This has led to a higher demand for healthcare products, including cold and cough remedies. Additionally, improvements in healthcare infrastructure and access to pharmacies have made these remedies more readily available to a larger population. In conclusion, the Cold & Cough Remedies (Pharmacies) market in Western Africa is developing due to customer preferences for over-the-counter remedies, the increasing demand for natural and herbal options, the rise of private label brands, the prevalence of seasonal outbreaks, and underlying macroeconomic factors such as economic growth and improved healthcare infrastructure.

Methodology

Data coverage:

The data encompasses B2C enterprises. Figures are based on offline and online spending by consumers, including VAT. Not included are B2B and B2G sales, or other pharmaceutical sales through hospitals or retail stores such as supermarkets.

Modeling approach:

Market sizes are determined through a bottom-up approach, building on specific predefined factors for each market market. As a basis for evaluating markets, we use industry associations, third-party studies and reports and survey results from our primary research (e.g., the Statista Global Consumer Survey). In addition, we use relevant key market indicators and data from country-specific associations, such as healthcare expenditure per country, consumer healthcare spending, GDP and internet penetration. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the relevant market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods. For forecasting digital trends such as the online-pharmacy sales share we use exponential trend smoothing and the s-curve method. The main drivers are healthcare expenditure per country and consumer healthcare spending.

Additional notes:

The data is modeled using current exchange rates. The impact of the COVID-19 pandemic and the Russia-Ukraine war are considered at a country-specific level. The market is updated twice a year. GCS data is reweighted for representativeness.

Overview

  • Revenue
  • Analyst Opinion
  • Global Comparison
  • Methodology
Please wait

Contact

Get in touch with us. We are happy to help.
Statista Locations
Contact Meredith Alda
Meredith Alda
Sales Manager– Contact (United States)

Mon - Fri, 9am - 6pm (EST)

Contact Yolanda Mega
Yolanda Mega
Operations Manager– Contact (Asia)

Mon - Fri, 9am - 5pm (SGT)

Contact Kisara Mizuno
Kisara Mizuno
Senior Business Development Manager– Contact (Asia)

Mon - Fri, 10:00am - 6:00pm (JST)

Contact Lodovica Biagi
Lodovica Biagi
Director of Operations– Contact (Europe)

Mon - Fri, 9:30am - 5pm (GMT)

Contact Carolina Dulin
Carolina Dulin
Group Director - LATAM– Contact (Latin America)

Mon - Fri, 9am - 6pm (EST)